Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: A systematic review

Autism

Volumn 21, Issue 4, 2017, Pages 387-402

  Höfer, Juliana ^a   Hoffmann, Falk ^a   Bachmann, Christian ^b  

^a UNIVERSITY OF OLDENBURG   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

autism spectrum disorder; complementary and alternative medicine; prevalence; systematic review

Indexed keywords

ALTERNATIVE MEDICINE; AUTISM; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COMPLEMENTARY AND ALTERNATIVE MEDICINE; DIETARY SUPPLEMENT; DISEASE SEVERITY; HUMAN; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; ADOLESCENT; AGE; CHILD; FEMALE; MALE; PROCEDURES; SEX FACTOR; UTILIZATION;

ADOLESCENT; AGE FACTORS; AUTISM SPECTRUM DISORDER; CHILD; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 85018779385     PISSN: 13623613     EISSN: 14617005     Source Type: Journal    
DOI: 10.1177/1362361316646559     Document Type: Review

References (62)

1. Akins RS, Krakowiak P, Angkustsiri K, et al. (2014) Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. Journal of Developmental and Behavioral Pediatrics 35 (1): 1-10.
2. American Psychiatric Association (APA) (2013) Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, TX: American Psychiatric Publishing.
3. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators and Centers for Disease Control and Prevention (2012) Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008. Morbidity and Mortal Weekly Report: Surveillance Summaries 61 (3): 1-19.
4. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators and Centers for Disease Control and Prevention (2014) Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. Morbidity and Mortal Weekly Report: Surveillance Summaries 63 (2): 1-21.
5. Bachmann CJ, Manthey T, Kamp-Becker I, et al. (2013) Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany. Research in Developmental Disabilities 34 (9): 2551-2563.
6. Bent S, Hendren RL, Zandi T, et al. (2014) Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. Journal of the American Academy of Child and Adolescent Psychiatry 53 (6): 658-666.
7. Bilgic A, Congologlu A, Herguner S, et al. (2013) Use of complementary and alternative medicine in children with autism spectrum disorders: a multicenter study. Noropsikiyatri Arsivi-Archives of Neuropsychiatry 50 (3): 237-243.
8. Birdee GS, Phillips RS, Davis RB, et al. (2010) Factors associated with pediatric use of complementary and alternative medicine. Pediatrics 125 (2): 249-256.
9. Bishop FL, Prescott P, Chan YK, et al. (2010) Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125 (4): 768-776.
10. Bishop FL, Rea A, Lewith H, et al. (2011) Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. Prostate Cancer and Prostatic Diseases 14 (1): 1-13.
11. Black LI, Clarke TC, Barnes PM, et al. (2015) Use of complementary health approaches among children aged 4-17 years in the United States: national Health Interview Survey, 2007-2012. National Health Statistics Reports 78: 1-19.
12. Bowker A, D'Angelo NM, Hicks R, et al. (2011) Treatments for autism: parental choices and perceptions of change. Journal of Autism and Developmental Disorders 41 (10): 1373-1382.
13. Brown KA, Patel DR, (2005) Complementary and alternative medicine in developmental disabilities. Indian Journal of Pediatrics 72 (11): 949-952.
14. Carter M, Roberts J, Williams K, et al. (2011) Interventions used with an Australian sample of preschool children with autism spectrum disorders. Research in Autism Spectrum Disorders 5 (3): 1033-1041.
15. Chan E, Rappaport LA, Kemper KJ, (2003) Complementary and alternative therapies in childhood attention and hyperactivity problems. Journal of Developmental and Behavioral Pediatrics 24 (1): 4-8.
16. Christon LM, Mackintosh VH, Myers BJ, (2010) Use of complementary and alternative medicine (CAM) treatments by parents of children with autism spectrum disorders. Research in Autism Spectrum Disorders 4 (2): 249-259.
17. Clarke TC, Black LI, Stussman BJ, et al. (2015) Trends in the use of complementary health approaches among adults: United States, 2002-2012. National Health Statistics Reports 79: 1-16.
18. Committee on Children with Disabilities (2001) American academy of pediatrics: counseling families who choose complementary and alternative medicine for their child with chronic illness or disability. Pediatrics 107 (3): 598-601.
19. Elsabbagh M, Divan G, Koh Y-J, et al. (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Research 5 (3): 160-179.
20. Ernst E, Cassileth B, (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83 (4): 777-782.
21. Gabriels RL, Pan Z, Dechant B, et al. (2015) Randomized controlled trial of therapeutic horseback riding in children and adolescents with autism spectrum disorder. Journal of the American Academy of Child and Adolescent Psychiatry 54 (7): 541-549.
22. Goin-Kochel RP, Myers BJ, Mackintosh VH, (2007) Parental reports on the use of treatments and therapies for children with autism spectrum disorders. Research in Autism Spectrum Disorders 1 (3): 195-209.
23. Golnik AE, Ireland M, (2009) Complementary alternative medicine for children with autism: a physician survey. Journal of Autism and Developmental Disorders 39 (7): 996-1005.
24. Granich J, Hunt A, Ravine D, et al. (2014) High use of complementary and alternative medication among children with autism is not associated with the severity of core symptoms. Journal of Autism. Available at: http://www.hoajonline.com/autism/2054-992X/1/4
25. Grant SJ, Bin YS, Kiat H, et al. (2012) The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health 12: 299.
26. Green VA, Pituch KA, Itchon J, et al. (2006) Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities 27 (1): 70-84.
27. Hall SE, Riccio CA, (2012) Complementary and alternative treatment use for autism spectrum disorders. Complementary Therapies in Clinical Practice 18 (3): 159-163.
28. Hansen SN, Schendel DE, Parner ET, (2015) Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices. Journal of American Medical Association 169 (1): 56-62.
29. Hanson E, Kalish LA, Bunce E, et al. (2007) Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism and Developmental Disorders 37 (4): 628-636.
30. Harrington JW, Patrick PA, Edwards KS, et al. (2006a) Parental beliefs about autism: implications for the treating physician. Autism: The International Journal of Research and Practice 10 (5): 452-462.
31. Harrington JW, Rosen L, Garnecho A, et al. (2006b) Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. Journal of Developmental and Behavioral Pediatrics 27 (suppl. 2): S156-S161.
32. Harris PE, Cooper KL, Relton C, et al. (2012) Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. International Journal of Clinical Practice 66 (10): 924-939.
33. Huang A, Seshadri K, Matthews TA, (2013) Parental perspectives on use, benefits, and physician knowledge of complementary and alternative medicine in children with autistic disorder and attention-deficit/hyperactivity disorder. Journal of Alternative and Complementary Medicine 19 (9): 746-750.
34. IACC/OARC (2012) Spectrum Disorder Research Portfolio Analysis Web Tool. Subcategory: complementary, Dietary, and Alternative Detail. Washington, DC: US Department of Health & Human Services. Available at: https://iacc.hhs.gov/apps/portfolio-analysis-web-tool/subcat?subcatId=5282&fy=2010 (. accessed 6 October 2015).
35. Italia S, Wolfenstetter SB, Teuner CM, (2014) Patterns of Complementary and Alternative Medicine (CAM) use in children: a systematic review. European Journal of Pediatrics 173 (11): 1413-1428.
36. Karst JS, Van Hecke AV, (2012) Parent and family impact of autism spectrum disorders: a review and proposed model for intervention evaluation. Clinical Child and Family Psychology Review 15 (3): 247-277.
37. Kemper KJ, Gardiner P, Birdee GS, (2013) Use of complementary and alternative medical therapies among youth with mental health concerns. Academic Pediatrics 13 (6): 540-545.
38. Khanna R, Madhavan SS, Smith MJ, et al. (2011) Assessment of health-related quality of life among primary caregivers of children with autism spectrum disorders. Journal of Autism and Developmental Disorders 41 (9): 1214-1227.
39. Kompoliti K, Fan W, Leurgans S, (2009) Complementary and alternative medicine use in Gilles de la Tourette syndrome. Movement disorders. Official Journal of the Movement Disorder Society 24 (13): 2015-2019.
40. Levy SE, Hyman SL, (2015) Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America 24 (1): 117-143.
41. Levy SE, Mandell DS, Merhar S, et al. (2003) Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. Journal of Developmental and Behavioral Pediatrics 24 (6): 418-423.
42. Lofthouse N, Hendren R, Hurt E, et al. (2012) A review of complementary and alternative treatments for autism spectrum disorders. Autism Research and Treatment 2012: 870391.
43. Matson JL, Williams LW, (2015) The curious selection process of treatments for Autism Spectrum Disorders. Research in Autism Spectrum Disorders 9: 21-25.
44. Olsen SA, (2009) A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occupational Therapy International 16 (1): 57-70.
45. Ouellette-Kuntz H, Coo H, Lam M, et al. (2013) The changing prevalence of autism in three regions of Canada. Journal of Autism and Developmental Disorders 44 (1): 120-136.
46. Perrin JM, Coury DL, Hyman SL, (2012) Complementary and alternative medicine use in a large pediatric autism sample. Pediatrics 130 (suppl. 2): S77-S82.
47. Posadzki P, Watson LK, Alotaibi A, et al. (2013) Prevalence of use of complementary and alternative medicine (cam) by patients/consumers in the UK: systematic review of surveys. Clinical Medicine 13 (2): 126-131.
48. Prussing E, Sobo EJ, Walker E, et al. (2005) Between "desperation" and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with down syndrome. Social Science & Medicine 60 (3): 587-598.
49. Quandt SA, Verhoef MJ, Arcury TA, (2009) Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). Journal of Alternative and Complementary Medicine 15 (4): 331-339.
50. Rey JM, Walter G, Soh N, (2008) Complementary and alternative medicine (CAM) treatments and pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry 47 (4): 364-368.
51. Ricotti V, Delanty N, (2006) Use of complementary and alternative medicine in epilepsy. Current Neurology and Neuroscience Reports 6 (4): 347-353.
52. Salomone E, Charman T, McConachie H, et al. (2015) Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe. European Journal of Pediatrics 174 (10): 1277-1285.
53. Surette S, Vanderjagt L, Vohra S, (2013) Surveys of complementary and alternative medicine usage: a scoping study of the paediatric literature. Complementary Therapies in Medicine 21 (suppl.1): S48-S53.
54. Valicenti-McDermott M, Burrows B, Bernstein L, et al. (2013) Use of complementary and alternative medicine in children with autism and other developmental disabilities: associations with ethnicity, child comorbid symptoms, and parental stress. Journal of Child Neurology 29 (3): 360-367.
55. Van Heijst BFC, Geurts HM, (2015) Quality of life in autism across the lifespan: a meta-analysis. Autism: The International Journal of Research and Practice 19 (2): 158-167.
56. Volkmar F, Siegel M, Woodbury-Smith M, et al. (2014) Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. Journal of the American Academy of Child and Adolescent Psychiatry 53 (2): 237-257.
57. Whitehouse AJO, (2013) Complementary and alternative medicine for autism spectrum disorders: rationale, safety and efficacy. Journal of Paediatrics and Child Health 49 (9): 438-442.
58. Witwer A, Lecavalier L, (2005) Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology 15 (4): 671-681.
59. Wong H, Smith RG, (2006) Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. Journal of Autism and Developmental Disorders 36 (7): 901-909.
60. Wong V, (2009) Use of complementary and alternative medicine (CAM) in autism spectrum disorder (ASD): comparison of Chinese and western culture (part A). Journal of Autism and Developmental Disorders 39 (3): 454-463.
61. World Health Organization (WHO) (2000) Traditional Medicine: Definitions. Geneva: World Health Organization. Available at: http://www.who.int/medicines/areas/traditional/definitions/en/ (. accessed 8 September 2015).
62. Zuzak TJ, Boňková J, Careddu D, et al. (2013) Use of complementary and alternative medicine by children in Europe: published data and expert perspectives. Complementary Therapies in Medicine 21 (suppl.1): S34-47.